Number of the records: 1
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring
- 1.
SYSNO 0564874 Title Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring Author(s) Wasserbauer, M. (CZ)
Hlava, S. (CZ)
Drábek, J. (CZ)
Šťovíček, J. (CZ)
Minaříková, P. (CZ)
Nedbalová, L. (CZ)
Drasar, T. (CZ)
Zadorová, Z. (CZ)
Dolina, J. (CZ)
Konečný, S. (CZ)
Kojecky, V. (CZ)
Koželuhová, J. (CZ)
Černíková, P. (CZ)
Pichlerová, D. (CZ)
Kučerová, B. (CZ)
Coufal, Štěpán (MBU-M) ORCID, RID
Keil, R. (CZ)Source Title PLoS ONE. Roč. 17, 8 August (2022). - : Public Library of Science Article number e0271299 Document Type Článek v odborném periodiku Institutional support MBU-M - RVO:61388971 Language eng Country US Keywords Adalimumab * Biosimilar Pharmaceuticals * Colitis * Ulcerative * Crohn Disease * Humans * Inflammatory Bowel Diseases * Prospective Studies * Remission Induction * Treatment Outcome Cooperating institutions Univerzita Karlova v Praze, 1. lékařská fakulta (Czech Republic)
Univerzita Karlova v Praze, 2. lékařská fakulta (Czech Republic)
IBD Centrum a Gastroenterologie Turnov (Czech Republic)URL https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271299 Permanent Link https://hdl.handle.net/11104/0336441
Number of the records: 1